Atara Biotherapeutics Inc, Cellectis SA and 2Seventy Bio Inc at Citi BioPharma Conference- Panel Transcript
(technical difficulty)
excellent CEOs from cell therapy companies across the United States. Pascal Touchon from Atara; Nick Leschly, 2seventy bio; and Andre Choulika from Cellectis. Welcome, everyone. Thank you so much for joining.
Questions & Answers
So maybe just to start, if each of you could spend 2 or 3 minutes just giving a high-level overview of your company and what are the strengths and differentiating qualities for each of your cell therapy platforms, and then we can go into more specifics after that. So you want to start, Pascal?
Yes. Pleasure. Thank you for inviting us to this panel. Atara Bio is a leading company in the field of allogeneic cell therapy, developing transformative therapies for patients in need in both oncology and autoimmune disease. In fact, we are leveraging
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
